1110.HK Stock Analysis
11
Uncovered
Kingworld Medicines Group Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Kingworld Medicines Group Ltd. is an investment company, which engages in the distribution of imported branded pharmaceutical and healthcare products. The company is headquartered in Shenzhen, Guangdong and currently employs 1,032 full-time employees. The company went IPO on 2010-11-25. The Company’s products include cough and phlegm relieving, gastrointestinal, vitamin, orthopedics, cardiovascular, influenza and others. The firm operates through two business segments. The Distribution Sales of Pharmaceutical and Healthcare Products segment is engaged in the distribution and sales of branded imported pharmaceutical and healthcare products primarily in Hong Kong and the People’s Republic of China (PRC). The Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices segment is engaged in the manufacture and sales of electrotherapeutic and physiotherapeutic devices, as well as general medical examination devices in the PRC.